WIPO logo
Celular | Deutsch | English | Español | Français | 日本語 | 한국어 | Русский | 中文 | العربية |
PATENTSCOPE

Pesquisa nas coleções internacionais e nacionais de patentes
World Intellectual Property Organization
Pesquisa
 
Navegação
 
Traduzir
 
Opções
 
Notícias
 
Conectar-se
 
Ajuda
 
Tradução automática
1. (WO2015002996) PRECISE DELIVERY OF THERAPEUTIC AGENTS TO CELL MITOCHONDRIA FOR ANTI-CANCER THERAPY
Dados bibliográficos mais recentes no arquivo da Secretaria Internacional   

№ de pub.:    WO/2015/002996    № do pedido internacional:    PCT/US2014/045131
Data de publicação: 08.01.2015 Data de depósito internacional: 01.07.2014
CIP:
A61P 35/00 (2006.01), A61K 31/352 (2006.01)
Requerentes: UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. [US/US]; Boyd Graduate Studies Research Center Athens, GA 30602 (US)
Inventores: SHANTA, Dhar; (US).
RAKESH, Pathak; (US)
Mandatário: CURFMAN, Christopher, L.; (US)
Dados da prioridade:
61/841,657 01.07.2013 US
Título (EN) PRECISE DELIVERY OF THERAPEUTIC AGENTS TO CELL MITOCHONDRIA FOR ANTI-CANCER THERAPY
(FR) ADMINISTRATION PRÉCISE D'AGENTS THÉRAPEUTIQUES EN DIRECTION DES MITOCHONDRIES CELLULAIRES DANS LE CADRE D'UNE THÉRAPIE ANTICANCÉREUSE
Resumo: front page image
(EN)Described is a targeted molecular scaffold for construction of a metabolic inhibitor loaded with cancer-cell specific activity and anti-tumor immunity. Incorporation of a mitochondria targeting moiety such as triphenylphosphonium cation through a biodegradable linker in allowed for mitochondria targeting of certain metabolic inhibitors like dichloroacetic acid (DCA).
(FR)La présente invention concerne un tuteur moléculaire ciblé servant à l'élaboration d'un inhibiteur métabolique caractérisé par une activité spécifique à l'encontre des cellules cancéreuses et par une immunité anti-tumorale. L'intégration d'une fraction de ciblage en direction des mitochondries, telle que le cation triphénylphosphonium, par l'intermédiaire d'une séquence de liaison biodégradable est possible pour le ciblage en direction des mitochondries de certains inhibiteurs métaboliques comme l'acide dichloroacétique.
Estados designados: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Língua de publicação: English (EN)
Língua de depósito: English (EN)